ArticleBioactive materials2027
A self-crosslinkable, adhesive intestine-derived extracellular matrix hydrogel enhances organoid retention and restores intestinal barrier integrity.
Article in Bioactive materials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disruption of the intestinal barrier impairs essential functions of the gastrointestinal tract and triggers severe inflammation. Accordingly, transplantation of intestinal organoids restores the integrity of the injured intestinal barrier by promoting regeneration. However, the dynamic mucosal microenvironment of the intestine hinders effective retention of transplanted organoids, thereby limiting their therapeutic efficacy. To address this challenge, this study introduces a pyrogallol (PG)-conjugated intestine-derived extracellular matrix (IEM) (IEM-PG) as a scaffold for effective organoid transplantation. The dual crosslinking of IEM-based fibrillogenesis and oxidative PG coupling enabled IEM-PG to form a robust hydrogel scaffold without crosslinking agents under physiological conditions. Moreover, the IEM-PG hydrogel exhibited enhanced mechanical properties, superior bio-adhesion, and greater resistance to enzymatic degradation than the pristine IEM. The IEM-PG hydrogel was also highly biocompatible and did not adversely affect the viability and development of colonic organoids. The solution-type IEM-PG was readily injected into colonic tissue, thus allowing IEM-PG to initially spread along the intestinal lining. Transplantation of colonic organoids using IEM-PG in a mouse colonic ulcer model demonstrated effective cell retention in the intestinal tract, thereby restoring the structural integrity and function of the intestinal barrier. The study further demonstrated that the patch-type IEM-PG hydrogel was effective for the transplantation of colonic assembloids and the treatment of colonic perforation. Overall, this study presents the IEM engineered with an adhesive motif as a self-crosslinking hydrogel platform for organoid/assembloid transplantation and intestinal tissue repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.